Latest Innovation And Technology News

Synertec Corporation has won operational technology contracts exceeding $1 million with Sydney Water, marking a significant step in its national expansion within Australia's water infrastructure sector.

Chrysos Corporation Limited reported a robust 1H FY26 with revenue up 49% and EBITDA soaring 152%, driven by expanding adoption of its PhotonAssay technology and strategic global deployments.

Elevra Lithium has signed a non-binding MoU to supply up to 144,000 tonnes of spodumene concentrate annually to Mangrove Lithium, supporting a new Canadian lithium conversion facility and strengthening domestic battery material production.

Provaris Energy has successfully completed the first phase of engineering design for a pioneering large-scale liquefied CO₂ tank, advancing carbon capture storage solutions with Yinson Production.

NoviqTech Limited launches Coralia, a large-scale biochar carbon removal initiative aimed at helping data centres achieve net zero emissions while restoring the Great Barrier Reef catchment. The project taps into the booming carbon removal market driven by tech giants and environmental urgency.

Locksley Resources has reported outstanding high-grade antimony assay results from its Desert Antimony Mine in California, with samples reaching up to 26.1% Sb. This breakthrough supports the company’s plans for a pilot plant aimed at domestic production critical to U.S. defense needs.

FortifAI Limited has completed its acquisition of FastAI Pty Ltd, gaining control of the innovative Nol8 technology and appointing seasoned executive Yosef Keret as director and Celerriem CEO.

Biome Australia has partnered with Fullscript to distribute its Activated Probiotics range across Canada, complementing its existing wholesale network and marking a key step in its international growth.

Next Science Limited has updated the payment date for its cash return of capital to 10 February 2026, following its recent asset sale and pending ASX delisting.

EVE Health Group has transitioned from development to commercial rollout, delivering first patient prescriptions of Dyspro™ and completing initial manufacturing of Libbo™, supported by a $1.1 million capital raise.

Cadoux Limited has made significant progress in its High Purity Alumina (HPA) project and its 50% owned Minhub rare earths processing initiative, advancing engineering design and market engagement amid growing global demand for critical minerals.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.